Dr. Martina Bezdickova, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-634-7900 Fax: 845-634-0632 |
Dr. Carly Michelle Rice-iocolano, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-496-5437 |
Dr. Barbara Beyer, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-634-7900 Fax: 845-634-0632 |
Dr. Sharen Casazza, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 21 South St, Washingtonville, NY 10992 Phone: 845-496-5436 Fax: 845-496-7640 |
Dr. Patricia Mangan, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-634-7900 Fax: 845-634-0632 |
Dr. Barbara Gannon, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-634-7900 Fax: 845-634-0632 |
Dr. Ludivinia Gonzales Caballero, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 25 South St, Washingtonville, NY 10992 Phone: 845-496-5323 |
Dr. Suzanne Kaseta, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Weathervane Dr, Washingtonville, NY 10992 Phone: 845-634-7900 Fax: 845-634-0632 |
News Archive
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.
With millions of motorists set to hit the road for the bank holiday weekend, drivers have been urged to close windows and turn off fans while in traffic jams to avoid breathing in dangerously high levels of air pollution.
CHX Technologies Inc., a private Canadian pharmaceutical company that is developing new treatments for the prevention of dental diseases, today announced successful results in its final controlled pivotal trial of Prevora, its proprietary antibacterial tooth coating for the prevention of cavities. The trial surpassed objectives set by the Food and Drug Administration (FDA) protocol, clearing the way for CHX to start the process of seeking FDA approval for use in the United States.
MedImmune today announced that ten abstracts on progress being made in various oncology programs will be presented during the Annual Meeting of the American Association for Cancer Research in Washington, DC from April 17 to 21.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
› Verified 3 days ago